Basis: Current FMP quote-based enterprise value / four-quarter operating income. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBIT ratio is N/A as of 2026-10-06T14:07:17.726Z.
Calculation as of: 2026-10-06T14:07:17.726Z.
Quote observation: 2026-10-06T13:52:59.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 00b46e2a658eb37d32f3c4bb775d4183c2cde6b20987a1f72f3e7425ee882fe4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-03-10.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBIT RATIO
N/A
EV/EBIT RATIO AVG TTM
N/A
EV/EBIT RATIO AVG 3Y
N/A
EV/EBIT RATIO AVG 5Y
N/A
EV/EBIT RATIO AVG 10Y
N/A
EV/EBIT RATIO AVG 15Y
N/A
EV/EBIT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$156.62M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$158.01M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$148.07M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$160.80M
EV/EBIT Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBIT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LifeMD, Inc. (LFMDP) | $153.56M | N/A | N/A | N/A | N/A |
| Codexis, Inc. (CDXS)vs › | $154.76M | N/A | N/A | N/A | N/A |
| Cardiol Therapeutics Inc. (CRDL)vs › | $155.62M | N/A | N/A | N/A | N/A |
| Jyong Biotech Ltd. Ordinary Shares (MENS)vs › | $156.62M | N/A | N/A | N/A | N/A |
| Anavex Life Sciences Corp. (AVXL)vs › | $158.01M | N/A | N/A | N/A | N/A |
| Acumen Pharmaceuticals, Inc. (ABOS)vs › | $148.07M | N/A | N/A | N/A | N/A |
| Inogen, Inc. (INGN)vs › | $159.74M | N/A | 189.93x | 95.49x | 94.46x |
| Korsana Biosciences, Inc. (KRSA)vs › | $146.95M | N/A | N/A | N/A | N/A |
| ALX Oncology Holdings Inc. (ALXO)vs › | $160.80M | N/A | N/A | N/A | N/A |
| Immuneering Corporation (IMRX)vs › | $145.39M | N/A | N/A | N/A | N/A |
EV/EBIT = Enterprise Value / EBIT (TTM)
Enterprise value to EBIT compares total company value to operating earnings, accounting for depreciation unlike EV/EBITDA.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBIT RATIO |
|---|---|
| 2026-03-10 | 1533.82x |
| 2026-03-09 | 1495.42x |
| 2026-03-06 | 1490.70x |
| 2026-03-05 | 1496.76x |
| 2026-03-04 | 1496.76x |
| 2026-03-03 | 1497.44x |
| 2026-03-02 | 1480.59x |
| 2026-02-27 | 1510.24x |
| 2026-02-26 | 1510.24x |
| 2026-02-25 | 1502.83x |
| 2026-02-24 | 1502.83x |
| 2026-02-23 | 1488.68x |
| 2026-02-20 | 1507.54x |
| 2026-02-19 | 1504.18x |
| 2026-02-18 | 1497.44x |
| 2026-02-17 | 1494.07x |
| 2026-02-13 | 1490.70x |
| 2026-02-12 | 1483.96x |
| 2026-02-11 | 1477.23x |
| 2026-02-10 | 1483.96x |
| 2026-02-09 | 1477.23x |
| 2026-02-06 | 1504.18x |
| 2026-02-05 | 1501.48x |
| 2026-02-04 | 1490.70x |
| 2026-02-03 | 1504.18x |
| 2026-02-02 | 1509.57x |
| 2026-01-30 | 1467.12x |
| 2026-01-29 | 1507.54x |
| 2026-01-28 | 1514.28x |
| 2026-01-27 | 1507.54x |
| 2026-01-26 | 1524.39x |
| 2026-01-23 | 1524.39x |
| 2026-01-22 | 1489.35x |
| 2026-01-21 | 1488.01x |
| 2026-01-20 | 1499.46x |
| 2026-01-16 | 1496.09x |
| 2026-01-15 | 1506.20x |
| 2026-01-14 | 1492.05x |
| 2026-01-13 | 1475.88x |
| 2026-01-12 | 1450.28x |
| 2026-01-09 | 1477.23x |
| 2026-01-08 | 1477.23x |
| 2026-01-07 | 1476.55x |
| 2026-01-06 | 1481.94x |
| 2026-01-05 | 1508.89x |
| 2026-01-02 | 1543.25x |
| 2025-12-31 | 1459.71x |
| 2025-12-30 | 1433.43x |
| 2025-12-29 | 1419.96x |
| 2025-12-26 | 1409.18x |
| 2025-12-24 | 1412.55x |
| 2025-12-23 | 1417.26x |
| 2025-12-22 | 1413.22x |
| 2025-12-19 | 1386.95x |
| 2025-12-18 | 1384.93x |
| 2025-12-17 | 1306.10x |
| 2025-12-16 | 1436.80x |
| 2025-12-15 | 1457.01x |
| 2025-12-12 | 1508.89x |
| 2025-12-11 | 1497.44x |
| 2025-12-10 | 1499.46x |
| 2025-12-09 | 1531.12x |
| 2025-12-08 | 1524.39x |
| 2025-12-05 | 1518.32x |
| 2025-12-04 | 1507.54x |
| 2025-12-03 | 1510.91x |
| 2025-12-02 | 1527.76x |
| 2025-12-01 | 1529.10x |
| 2025-11-28 | 1558.75x |
| 2025-11-26 | 1510.24x |
| 2025-11-25 | 1521.02x |
| 2025-11-24 | 1554.03x |
| 2025-11-21 | 1554.03x |
| 2025-11-20 | 1554.03x |
| 2025-11-19 | 1563.46x |
| 2025-11-18 | 1563.46x |
